Literature DB >> 22868013

MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure.

Om Parkash1, Khalid Mumtaz, Saeed Hamid, Syed Hasnain Ali Shah, S M Wasim Jafri.   

Abstract

OBJECTIVE: To compare Model for End-stage Liver Disease Score (MELD Score, MS) and King's College Hospital (KCH) criteria for finding correlation of mortality in non-acetaminophen induced acute liver failure (NAI-ALF). STUDY
DESIGN: An analytical cross-sectional study. PLACE AND DURATION OF STUDY: The Aga Khan University Hospital, Karachi, from 2005 to 2007.
METHODOLOGY: The study included patients with NAI-ALF. KCH criteria were labelled as good and bad prognosis groups. MELD score were calculated by using the MELD calculator. ROC was plotted and sensitivity analysis was done. ETA was used to see correlation between MELD and KCH.
RESULTS: Ninety-one patients with mean age of 32.5 + 16.3 years were studied; 49 were males (54%). Out of these, 57 patients died (63%); two leading causes of non-acetaminophen induced acute liver failure (NAI-ALF) were hepatitis hepatitis B virus (HBV) (n = 30, 33%) followed by hepatitis E virus in (n = 23, 25.3%). According to King's College Hospital (KCH) criteria, 50 patients (88%) who died had bad prognosis and 24 patients (70.6%) who survived had good prognosis. The ROC determined MELD score of 32 was the best predictor of mortality with sensitivity and specificity of 79% and 71%, respectively and positive predictive value (PPV) and negative predictive values (NPV) of 82% and 67% respectively. There was significant association between mortality and bad prognosis according to KCH criteria (p < 0.001). Overall mean MELD score (MMS) was 35.35 + 8.64. MMS on admission was 38 + 7.32 in patients who died and 30.7 + 8.77 in those who survived (p = < 0.001). MMS correlated equally with KCH criteria (ETA = 0.52).
CONCLUSION: The admission MELD score has an excellent utility and correlates equally with KCH criteria for mortality in NAI- ALF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868013     DOI: 08.2012/JCPSP.492496

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Live donor liver transplantation for antitubercular drug-induced acute liver failure.

Authors:  Akshay P Bavikatte; S Sudhindran; Puneet Dhar; O V Sudheer; G Unnikrishnan; Dinesh Balakrishnan; Ramachandran N Menon
Journal:  Indian J Gastroenterol       Date:  2017-01-09

2.  Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure.

Authors:  David G Koch; Holly Tillman; Valerie Durkalski; William M Lee; Adrian Reuben
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-13       Impact factor: 11.382

3.  Steroid use in acute liver failure.

Authors:  Jamuna Karkhanis; Elizabeth C Verna; Matthew S Chang; R Todd Stravitz; Michael Schilsky; William M Lee; Robert S Brown
Journal:  Hepatology       Date:  2013-12-24       Impact factor: 17.425

4.  A novel prognostic score for acute-on-chronic hepatitis B liver failure.

Authors:  Zhao-Quan Yi; Meng-Hou Lu; Xu-Wen Xu; Xiao-Yu Fu; De-Ming Tan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

5.  SOFA in the first 24 hours as an outcome predictor of acute liver failure.

Authors:  Edison Moraes Rodrigues-Filho; Rogério Fernandes; Anderson Garcez
Journal:  Rev Bras Ter Intensiva       Date:  2018-03

6.  Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.

Authors:  Koya Yasuda; Mea Asou; Tomohiko Asakawa; Makoto Araki
Journal:  J Med Case Rep       Date:  2020-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.